Pluristem Therapeutics Inc (PSTI)

[FDApproved]

Right At The Tippy Top !!!


Alongside the Cell and Gene Therapy Catapult, the founding partners of the RESTORE consortium comprise world leaders across academia, clinical research and industry, including Charité Universitätsmedizin Berlin (Germany), INSERM – Institut National de la Santé et de la Recherche (France), University of Zurich (Switzerland), Miltenyi Biotec GmbH (Germany), TissUse GmbH (Germany), Pluristem Ltd (Israel), Fondazione Telethon (Italy), University Minho (Portugal) and Innovation Acta S.r.l. (Italy).

"Clearly, Pluristem is part of the most important avant-garde in the most important new medical paradigm, i.e. harnessing the power of stem cells as therapeutic agents. Note that the article includes Pluristem in a very exclusive club: world leaders across academia, clinical research and industry"..Per Zzaatt